亚宝药业：关于ZY-A002获得药物临床试验批准通知书的公告

Group 1 - The core point of the article is that Yabao Pharmaceutical has received approval from the National Medical Products Administration for the clinical trial of ZY-A002 [2] Group 2 - The approval notification number for the clinical trial is 2025LP02459 [2]